Illumina同GenoLogics生命科学签署收购协议

  近日，Illumina公司已经同GenoLogics生命科学软件公司签署了一份收购协议，GenoLogics是一家致力于为生命科学组织机构提供实验室咨询管理系统的公司。
  此次收购预计将于8月底完成，Illumina公司完成收购后，GenoLogics公司将成为Illumina企业信息业务的一部分，将由高级副总裁和企业信息总经理Sanjay Chikarmane来管理。
  收购后Illumina公司将会开发并且销售GenoLogics的清晰的实验室信息管理系统（LIMS系统软件），LIMS系统主要为临床和研究性实验室提供服务，而清晰版的LIMS系统已经在Illumina测序仪器的帮助下得到了最大优化，可以明显改善试样的处理量，增加准确性以及快速周转的特性。
  Illumina公司总裁Francis deSouza表示，此次收购代表着我们公司开发测序新市场的意向，同时还可以改善当前基因组信息的工作流。将GenoLogics公司的产品加入到Illumina的旗下产品也将是Illumina公司将创新性的样品-结果解决方案展示给临床及实验室研究的一次有力的创新机会。
  Illumina和GenoLogics公司目前已经建立了长期的合作关系，而且此次收购也使得两家公司扩大了它们的产业分布，加速了它们产品的开发，并且可以为清晰的LIMS使用社区提供更多的支持和帮助。（转化医学网360zhyx.com）
  以上为转化医学网原创翻译整理，转载请注明出处和链接！
转化医学网推荐的新闻阅读：

Illumina to Buy GenoLogics
Illumina has signed an agreement to acquire GenoLogics Life Sciences Software, a developer of laboratory information management systems for life science organizations, for an undisclosed amount.

The acquisition is expected to close by the end of August. Following the close of purchase, GenoLogics will become part of Illumina's enterprise informatics business and will be under the purview of Sanjay Chikarmane, senior vice president and general manager of enterprise informatics.

The company developed and sells the GenoLogics' Clarity LIMS software, a LIM system tailored for the needs of clinical and research laboratories. Clarity LIMS, which is optimized for use with Illumina sequencing instruments, offers improved sample throughput, increased accuracy, and fast turnaround, among other benefits, according to GenoLogics.

Illumina President Francis deSouza said in a statement that the acquisition demonstrates his firm's "commitment to drive the adoption of sequencing in new markets and improve the genomic information workflow."

"Adding GenoLogics' products to Illumina's portfolio is another example of our continued commitment to bring innovative sample-to-answer solutions to research and clinical labs," he said.

"Illumina and GenoLogics have had a longstanding partnership," Michael Ball, GenoLogics' CEO, added, "and this acquisition will enable us to widen our distribution, accelerate our product development, and provide even greater support to the Clarity LIMS community."

（转化医学网360zhyx.com）